PIPITONE, Rosaria Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.926
EU - Europa 1.536
AS - Asia 489
AF - Africa 25
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.996
Nazione #
US - Stati Uniti d'America 4.919
IT - Italia 672
CN - Cina 311
FI - Finlandia 258
UA - Ucraina 140
IE - Irlanda 105
SG - Singapore 99
DE - Germania 96
GB - Regno Unito 82
RU - Federazione Russa 45
SE - Svezia 39
FR - Francia 23
IN - India 22
RO - Romania 19
CI - Costa d'Avorio 18
HK - Hong Kong 15
BE - Belgio 13
TR - Turchia 13
IR - Iran 9
KR - Corea 9
CL - Cile 8
NL - Olanda 8
CA - Canada 7
MK - Macedonia 6
AT - Austria 4
BG - Bulgaria 4
CH - Svizzera 4
EG - Egitto 4
JP - Giappone 4
PL - Polonia 4
BR - Brasile 3
EU - Europa 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
AR - Argentina 1
BY - Bielorussia 1
HR - Croazia 1
ID - Indonesia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 6.996
Città #
Fairfield 879
Ashburn 498
Woodbridge 406
Chandler 377
Houston 357
Seattle 329
Wilmington 324
Cambridge 285
Palermo 221
Ann Arbor 205
Des Moines 117
Dublin 105
Medford 99
Singapore 80
Altamura 68
Jacksonville 67
Princeton 65
Nanjing 63
Lawrence 60
New York 44
San Diego 40
Beijing 32
Rome 32
Boardman 30
Santa Clara 30
Dearborn 29
Shenyang 29
Jinan 26
Milan 23
Tulsa 22
Jiaxing 21
London 20
San Paolo di Civitate 20
Hebei 19
Abidjan 18
Changsha 18
Ludwigshafen am Rhein 17
Nanchang 17
Washington 16
Zhengzhou 14
Brussels 13
Izmir 12
Kumar 12
Central 10
Guangzhou 10
Los Angeles 10
Ningbo 10
Saint Petersburg 10
Chicago 9
Redwood City 9
Seongnam 9
Phoenix 8
Taizhou 8
Tianjin 8
Falls Church 7
Leigh 7
Bremen 6
Haikou 6
Helsinki 6
Prilep 6
Gothenburg 5
Hangzhou 5
Lanzhou 5
Norwalk 5
Orange 5
Ottawa 5
Auburn Hills 4
Bari 4
Cagliari 4
Como 4
Dallas 4
Favara 4
Hefei 4
Hong Kong 4
Hounslow 4
Kilburn 4
Lappeenranta 4
Pune 4
Amsterdam 3
Busto Arsizio 3
Catania 3
Chillan 3
Detroit 3
Durham 3
Gradara 3
Madison Heights 3
Sofia 3
Tappahannock 3
Taranto 3
Tehran 3
Venice 3
Bernareggio 2
Bollate 2
Brescia 2
Buonconvento 2
Frankfurt am Main 2
Fuzhou 2
Kemerovo 2
Kish 2
Lagos 2
Totale 5.433
Nome #
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 194
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 192
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 174
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 173
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 155
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides 152
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 149
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 148
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides 146
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 144
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 144
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity 142
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 140
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 140
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 138
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 138
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 136
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity 135
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 135
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 135
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES 134
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 131
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. 127
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 124
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 123
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 122
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 121
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. 120
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 120
Statin use and non-alcoholic steatohepatitis in at risk individuals 119
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 117
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 116
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 116
Novel Terphenyls and 3,5-Diaryl Isoxazole Derivatives Endowed with Growth Supporting and Antiapoptotic Properties 113
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors 113
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 113
Genetic predisposition to thrombophilia in inflammatory bowel disease 110
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. 109
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease 109
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. 106
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 101
Correlation between the single nucleotide polymorphism (SNP) rs4374383 in MERTK gene with the risk of development and progression of liver disease 100
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. 98
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. 97
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization 93
MAFLD: a multisystem disease 90
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization 83
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study 82
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis 75
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C 75
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 75
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease 72
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population 71
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 69
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 67
EPIGENETIC PROFILING AND THERAPEUTICS IN LIVER DISEASE 63
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 62
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis 56
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 46
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 39
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease 38
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 37
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line 37
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 35
Metabolic memory in diabetic foot syndrome (dfs): epigenetic changes of the expression of micro-rnas and single nucleotide polymorphisms (snps) frequency in a cohort of diabetic patients with and without foot ulceration and correlation with indices of endothelial and adipo-inflammatory dysfunction 33
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 33
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development 32
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease 32
Liver follicular helper T-cells in chronic hepatitis C 31
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 30
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 29
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity 16
Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4α, Lepr, and GK expression 16
The PD-1/PD-L1 Axis in the Biology of MASLD 13
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 11
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] 7
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 1
Totale 7.318
Categoria #
all - tutte 29.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.650 0 0 90 205 204 277 210 142 216 90 172 44
2020/20211.124 52 77 81 110 78 46 104 80 94 218 101 83
2021/2022891 57 187 25 29 23 32 50 59 94 114 76 145
2022/20231.202 107 240 23 113 107 196 104 80 125 7 55 45
2023/2024571 19 67 28 48 68 147 38 51 6 23 23 53
2024/2025222 38 88 96 0 0 0 0 0 0 0 0 0
Totale 7.318